放射免疫治疗中载体的研究进展

冯春玲

放射免疫治疗中载体的研究进展

冯春玲

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 2: (77-79)

引用本文:

Citation:

放射免疫治疗中载体的研究进展

冯春玲

300384 天津, 中国医学科学院中国协和医科大学血液学研究所血液病医院免疫室(硕士研究生)
中图分类号: R914.2

Research advances in carrier of radioimmunotherapy

FENG Chun-ling

Immunology Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300384, China
CLC number: R914.2

摘要: 放射免疫治疗是应用肿瘤细胞表面表达的特异性分子的单克隆抗体进行核素靶向治疗的一种新方法。通过改进放射性核素的载体,放射免疫治疗的技术不断发展、成熟,其应用范围不断扩展,在未来的疾病定位诊断及治疗中具有很高的应用价值。
- 放射免疫疗法 /
- 药物载体 /
- 肿瘤
Abstract: Radioimmunotherapy is a new method using nuclid targeting therapy, which utilizing monoclonal antibody labeled nuclid bindes to molecule expressing on carcinoma cell specificitilly. With improving in carrier of nuclid, radioimmunotherapy is more and more consummate, it will have higher value in use in diagnosis and therapy of diseases.
- Radioimmunotherapy /
- Drug carriers /
- Tumor
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Cheson BD. Radioimmunotheraphy of non-Hodgkin lymphomas.Blood, 2003, 101(2):391-398.
[2]	DeNardo GL. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs). Semin Nucl Med, 2005, 35(3):202-211.
[3]	Kaminski MS, Tuck M, Estes J, et al. ¹³¹Ⅰ-tositumomab therapy asinitial treatment for follicular lymphoma. N Engl J Med, 2005,352(5):441-449.
[4]	Dadachova E, Bryan RA, Apostolidis C, et al. Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection. Infect Dis, 2006, 193(10):1427-1436.
[5]	Buchsbaum DJ. Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs. Semin Nucl Med, 2004, 34(1):32-46.
[6]	Garambois V, Glaussel F, Foulquier E, et al. Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA)Gold 4 epitope and designed for radioimmunotherapy(RIT) of colorectalcancers. BMC Cancer, 2004, 75(4):1471-1482.
[7]	Chen ZN, Mi L, Xu J, et al. Targeting radioimmunotherapy of hepat-ocell carcinoma with iodine (¹³¹Ⅰ) metuximab injection:clinical phase Ⅰ/Ⅱ trials. Int J Radiat Oncol Biol Phys, 2006, 65(2):435-444.
[8]	Garkavij M, Samarzija M, Ewers SB, et al. Concurrent radiotherapy and tumor targeting with ¹³¹Ⅰn-HMFG1-F(ab')2 in patients with MUC1-positive non-small cell lung cancer. Anticancer Res, 2005, 25(6C):4663-4667.
[9]	Li G, Wang Y, Huang K, et al. The experimental study on the radioimmunotherapy of the nasopharyngeal carcinoma overexpressing HER2/neu in nude mice model with intratumoral injection of ¹⁸⁸Re-herceptin. Nucl Med Biol, 2005, 32(1):59-65.
[10]	Morandeau L, Benoist E, Loussouarn A, et al. Synthesis of new bivalent peptides for applications in the affinity enhancement system. Bioconjug Chem, 2005, 16(1):184-193.
[11]	Boerman OC, Oyen WJG, Corstens FHM. Between the scylla and charybdis of peptide radionuclide therapy:hitting the tumor and saving the kidney. Eur J Nucl Med, 2001, 28(10):1552-1554.
[12]	Bodei L, Hauekiewicz-Junak D, Grana C, et aL Receptor radionuclide theraphy with Y-DOTATOC in patients with medullary thyroid carcinomas. Cancer Biother Radiophasm, 2004, 19(1):65-71.
[13]	Schmitt A, Bernhardt P, Nilsson O, et al. Radiation therapy of small cell lung cancer with ¹¹⁷Lu-DOTA-Tyr3-octreotate in an animal model. J Nucl Med, 2004, 45(9):1542-1548.

[1]	于雷 , 陈红红 , 程文英 , 邵春林 . 放射性籽源薄层片植入治疗肿瘤的研究进展. 国际放射医学核医学杂志, 2006, 30(6): 369-372.
[2]	于晓明 , 樊飞跃 . 肿瘤放射免疫疗法研究进展. 国际放射医学核医学杂志, 2006, 30(2): 80-83.
[3]	郭艾楠 , 魏玲格 , 傅鹏 . ¹³¹I-肿瘤细胞核人鼠嵌合单克隆抗体治疗实体瘤的研究进展. 国际放射医学核医学杂志, 2013, 37(2): 120-123. doi: 10.3760/cma.j.issn.1673-4114.2013.02.015
[4]	王浩 , 施培基 , 周晓靓 , 王荣先 . RGD肽及其衍生物在肿瘤显像及治疗中的研究进展. 国际放射医学核医学杂志, 2007, 31(5): 274-277.
[5]	姚红霞 , 张金山 . 微波消融和¹³¹I-肿瘤细胞核人鼠嵌合单克隆抗体联合治疗肺癌. 国际放射医学核医学杂志, 2012, 36(5): 264-268, 306. doi: 10.3760/cma.j.issn.1673-4114.2012.05.002
[6]	黄帆 , 高阳 , 张玉民 , 杨丽军 , 褚丽萍 , 刘金剑 . 新型渗透性水凝胶作为载体用于肿瘤的放射性核素植入治疗. 国际放射医学核医学杂志, 2017, 41(2): 81-87. doi: 10.3760/cma.j.issn.1673-4114.2017.02.001
[7]	张锦明 , 田嘉禾 . 11C标记的放射性药物在PET-CT肿瘤诊断上的应用. 国际放射医学核医学杂志, 2005, 29(5): 232-237.
[8]	蒋宁一 , 熊玥 . 放射免疫导向治疗真菌感染灶的研究. 国际放射医学核医学杂志, 2008, 32(3): 137-139.
[9]	章鹤 , 宋建元 , 曹建平 . 肿瘤放射增敏药物的研究进展. 国际放射医学核医学杂志, 2014, 38(6): 408-411. doi: 10.3760/cma.j.issn.1673-4114.2014.06.014
[10]	魏莉 , 罗荣城 . 放射性核素标记抗CD20单克隆抗体治疗B细胞淋巴瘤的研究进展. 国际放射医学核医学杂志, 2006, 30(3): 153-157.